Nice gradual move up. At levels last seen in july. Fair value around $0.55 to $0.60 once we have approvals and achieve finance.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025